NCT04440176 - A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules | Biotech Hunter

Enrollment

309

Participants

Timeline

Start Date

June 17, 2020

Primary Completion Date

January 5, 2024

Study Completion Date

January 5, 2024

Conditions

Meningococcal Vaccine

Interventions

BIOLOGICAL

MenABCWY

Neisseria meningitidis group A, B, C, W, and Y vaccine

BIOLOGICAL

Saline

Placebo

Trial Locations (20)

22902

Pediatric Research of Charlottesville, LLC, Charlottesville

29405

Coastal Carolina Research Center, North Charleston

32829

Nona Pediatric Center, Orlando

36608

Alliance for Multispecialty Research, LLC, Mobile

45206

Cincinnati Children's Hospital Medical Center, Cincinnati

45414

Ohio Pediatric Research Association Inc., Dayton

68701

Velocity Clinical Research, Norfolk, Norfolk

76135

Benchmark Research, Fort Worth

Texas Health Resources, Fort Worth

78229

Diagnostics Research Group, San Antonio

84037

Wee Care Pediatrics, Kaysville

84057

Utah Valley Pediatrics - Timpanogos Office, Orem

84067

Alliance for Multispecialty Research, LLC, Roy

84075

Wee Care Pediatrics, Syracuse

84095

Alliance for Multispecialty Research, LLC, South Jordan

84107

Wasatch Pediatrics, Cottonwood Office, Murray

84109

J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City

84121

J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City

92123

California Research Foundation, San Diego

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati